| Scorecard |
|---|
|
2 / 5 Stars
|
|
Lipper
5
4
1
4
2
|
|
Zacks Investment Research
4
(Sell)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
E+
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 0.22 | 0.22 |
| Stocks | 6.58 | 6.58 |
| Bonds | 0.0 | 0.0 |
| Other | 0.55 | 0.55 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 92.66 | 92.66 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| ING Groep N.V. | INGA | --- | 3.67 |
| Credit Suisse Group | CSGN | --- | 3.64 |
| BNP Paribas | BNP | --- | 2.92 |
| Roche Holding AG | RHHVF | 23.65 | 2.63 |
| Baker Hughes Inc. | BHI | 9.28 | 2.43 |
| Cisco Systems Inc | CSCO | 4.58 | 2.34 |
| Tesco PLC | TSCO | --- | 2.28 |
| Sanofi | SAN | --- | 2.28 |
| AXA SA | AXAHF | 4.0 | 2.27 |
| GlaxoSmithKline PLC | GLAXF | 20.09 | 2.12 |
